Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026

Publisert: 12.12.2025

Oslo, December 9, 2025 – Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson’s Care with Simplified and Precise Dosing for Personalized Treatment

Publisert: 09.12.2025

Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt

Publisert: 03.12.2025

Navamedic ASA: Double digit growth in the 3rd quarter, 2025

Publisert: 28.10.2025

Navamedic ASA: Invitation to 2025 3rd quarter presentation

Publisert: 24.10.2025

Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical

Publisert: 17.10.2025